Advertising Market in China 2021

March 2021 | 22 pages | ID: A625981C110FEN
StrategyHelix Inc

US$ 450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The advertising market in China in terms of revenue is set to grow by US$ 67 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for advertising. The China advertising market is segmented on the basis of expenditure. By expenditure, it is categorized into online, outdoor, TV, and others. The online segment held the largest market share of 50.6% in 2020. Moreover, it is expected to witness the highest CAGR during the forecast period.

The report has profiled some of the key players of the market such as Inner Mongolia Yili Industrial Group Co. Ltd., SAIC Motor Corporation Limited, Shanghai Pharmaceuticals Holding Co. Ltd..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the advertising market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope
Expenditure: online, outdoor, TV, and others
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the China advertising market
Pinpoint growth sectors and trends for investment
Understand what the future of the advertising market in China looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. MARKET DATA & OUTLOOK

3.1 Market Value
3.2 Market Value Forecast

4. ADVERTISING MARKET BY EXPENDITURE

4.1 Online
4.2 Outdoor
4.3 Tv
4.4 Others

5. COMPANY PROFILES

5.1 Inner Mongolia Yili Industrial Group Co., Ltd.
5.2 SAIC Motor Corporation Limited
5.3 Shanghai Pharmaceuticals Holding Co., Ltd.

6. APPENDIX

6.1 About StrategyHelix
6.2 Disclaimer


More Publications